About this episode
In this episode, Professor Leon De Windt, co-founder of miRabilis Therapeutics at Maastricht University explains his journey of working with micro – RNA’s of the heart. He shares his path from America to Utrecht to now Maastricht and the different research carried out throughout. How are non – coding RNA’s linked to regenerative medicine? And why did COVID help in the credibility of these mRNA’s? Other than answering these questions, Professor De Windt shares his advice on entrepreneurship as well as his role in the European TRAIN-HEART association.
Get every episode summarized
Each time Biomed Unleashed publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Biomed Unleashed
Leadership, Education & Groundbreaking Regenerative Medicine – Prof. Pamela Habi...
Biomed Unleashed
Science, Entrepreneurship & Building the MERLN Research Institute – Prof. Clemen...
Biomed Unleashed
Rebuilding Bones, Repairing Lives: Immunity and RNA Therapies – Prof. Martijn va...
Biomed Unleashed
Commercialization of Regenerative Medicine Research – Prof. Marianne van der Ste...
Biomed Unleashed